Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women

By Christodoulakos G. E.   Lambrinoudaki I. V.   Creatsa M. G.   Economou E. V.   Siasou Z.   Panoulis C. P.   Kalligerou I.   Papadias C.  

Climacteric, Vol. 11, Iss. 2, 2008-01 ,pp. : 155-165

Informa Healthcare

Access to resources Recommend Favorite

Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?

By Sioulas V. D.   Politi E.   Rizos D.   Augoulea A.   Kyroudi A.   Sergentanis T. N.   Panoulis C.   Aravantinos L.   Creatsa M.   Lambrinoudaki I.  

Climacteric, Vol. 15, Iss. 2, 2012-04 ,pp. : 181-185

Informa Healthcare

Access to resources Recommend Favorite

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study

By Nickelsen T.   Creatsas G.   Rechberger T.   Depypere H.   Erenus M.   Quail D.   Arndt T.   Bonnar J.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 320-331

Informa Healthcare

Access to resources Recommend Favorite

Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens

By Lundström E.   Wilczek B.   von Palffy Z.   Söderqvist G.   von Schoultz B.  

Climacteric, Vol. 4, Iss. 1, 2001-03 ,pp. : 42-48

Informa Healthcare

Access to resources Recommend Favorite

Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women

By Christodoulakos G.E.   Panoulis C.P.C.   Lambrinoudaki I.V.   Dendrinos S.G.   Rizos D.A.   Creatsas G.C.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 112, Iss. 1, 2004-01 ,pp. : 74-79

Elsevier

Access to resources Recommend Favorite